Author: Jessica Esther Saraceni
COPENHAGEN, DENMARK—An international team of researchers have analyzed teeth from 152 formerly enslaved Africans whose […]Read More
COPENHAGEN, DENMARK—An international team of researchers have analyzed teeth from 152 formerly enslaved Africans whose […]Read More
How do wildfires grow into catastrophic events? By tracing the earliest detectable origins of the devastating 2015 equatorial Southeast Asian fires, researchers found that most large fires had multiple …Read More
How do wildfires grow into catastrophic events? By tracing the earliest detectable origins of the devastating 2015 equatorial Southeast Asian fires, researchers found that most large fires had multiple …Read More
Maersk has announced updated configurations for its AC1 and AC2 services connecting Far East Asia with Latin America’s Pacific coast.Read More
Maersk has announced updated configurations for its AC1 and AC2 services connecting Far East Asia with Latin America’s Pacific coast.Read More
German Chancellor Friedrich Merz welcomed French President Emmanuel Macron to the Noervenich air base near Cologne on Friday morning for the 26th Franco-German ministerial council.Read More
German Chancellor Friedrich Merz welcomed French President Emmanuel Macron to the Noervenich air base near Cologne on Friday morning for the 26th Franco-German ministerial council.Read More
Allergan Aesthetics, an AbbVie company (NYSE:ABBV), received European Commission approval for Boey (trenibotulinumtoxinE). Boey is described as the first rapid onset, short duration neurotoxin for the treatment of frown lines available in Europe. This approval gives AbbVie a differentiated addition to its aesthetics portfolio in Europe, an area where the company already has an established presence. By targeting frown lines with a rapid onset profile and shorter treatment duration, Boey is…Read More
Allergan Aesthetics, an AbbVie company (NYSE:ABBV), received European Commission approval for Boey (trenibotulinumtoxinE). Boey is described as the first rapid onset, short duration neurotoxin for the treatment of frown lines available in Europe. This approval gives AbbVie a differentiated addition to its aesthetics portfolio in Europe, an area where the company already has an established presence. By targeting frown lines with a rapid onset profile and shorter treatment duration, Boey is…Read More